Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q2 Program Management Update

17 Aug 2020 07:00

RNS Number : 2531W
Randall & Quilter Inv Hldgs Ltd
17 August 2020
 

 

 

Randall & Quilter Investment Holdings Ltd.

 

Q2 Program Management Update

 

17 August 2020

 

Randall & Quilter Investment Holdings Ltd. (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business, for the six months ended 30 June 2020.

 

Highlights

 

· Contracted Premium of $924.5 million (H1 2019: $431.6 million), a 114% increase

 

· Gross Written Premium of $247.2 million (H1 2019: $172.9 million), a 43% increase

 

· Economic Commission Revenue1 of $10.7 million (H1 2019: $5.7 million), an 88% increase

 

· Addition of 10 new programs bringing the total number of active programs to 36 (H1 2019: 26)

 

· Subsequent to the end of Q2 2020, four new programs were signed with Contracted Premium of approximately $200 million, all of which are expected to begin generating Gross Written Premium shortly

 

· Expected to enter the US Excess & Surplus ("E&S") Program Management market in Q4 2020

 

Commenting on the Program Management results, Alan Quilter, Group Chief Executive Officer, said:

 

"In the first half of 2020, our Program Management business, trading under the Accredited banner, continued to grow strongly. Importantly, this business has significant built-in growth through the 36 existing programs and 34 different distribution partners with whom we have secured contracts as of the end of Q2 2020. In addition, the four new programs we signed post the half year, are expected to generate in excess of $200 million of annual recurring Gross Written Premium when they achieve scale over the next 18 months.

 

We continue to see strong demand from new origination partners as existing insurance capacity faces capital challenges given the magnitude of the insured losses from Covid 19. Moreover, due to current market conditions, we expect to enter the US E&S Program Management market, a large addressable market in which we do not presently compete, in Q4 2020, accelerating our original plans. This launch will see Accredited achieve its strategic objective of being a comprehensive program management solutions provider in all its major markets."

 

R&Q will provide a further update on its Program Management business for the nine months ended 30 September 2020 in the fourth quarter.

 

1: Economic Commission Revenue represents the Commission Revenue from insurance policies already bound (written), regardless of the length of the underlying policy period (earned). We believe Economic Commission Revenue is a more appropriate measure of the revenue of the business during periods of high growth, due to larger than normal gap between Gross Written and Gross Earned (IFRS) Premium, and the corresponding fees.

 

 

Ends

Notes to Editors:

 

Randall & Quilter Investment Holdings Ltd.

 

Ken Randall

William Spiegel

 

Tel: +44 (0)7831 145440

Tel: +001 917 826 5877

Numis Securities Limited (Nominated Adviser)

Stuart Skinner / Huw Jeremy

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Shore Capital Stockbrokers Limited

Stephane Auton

James Thomas

Tel: 020 7408 4090

 

FTI Consulting

Edward Berry

Tom Blackwell

 

 

Tel: 020 3727 1046

 

About Accredited

 

Accredited is R&Q's Program Management business. Operating in the US, UK and Europe, Accredited is the only program carrier that has an AM Best A- credit rating in all these markets. In the US Accredited is licensed in all 50 states and in the UK/Europe it is licensed to write all classes of non-life business.

 

Accredited has also established a fully authorised UK branch to facilitate continued access to the large UK market, post Brexit. This branch will get the full benefit of Accredited Malta's A- rating from AM Best.

 

Accredited's (US) Financial Strength Category increased in 2019 to an AM Best category IX making it one of the highest rated program managers in the US and providing an important support for the business' continued growth.

 

About R&Q

 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities.

 

Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

For the financial year ended 31 December 2019 R&Q reported pre-tax profits of over £40 million.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website : www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPFMLTMTJBBLM
Date   Source Headline
5th Oct 20187:00 amRNSNotice of General Meeting
2nd Oct 20183:11 pmRNSAcquisition of WCIC
28th Sep 201810:07 amRNSNotification of major holdings
20th Sep 20181:00 pmRNSResult of General Meeting
20th Sep 20187:00 amRNSR&Q writes Novation for Barbados based captive
19th Sep 20187:01 amRNSAcquisition
19th Sep 20187:01 amRNSAcquisition
19th Sep 20187:00 amRNSInterim Results
11th Sep 20187:00 amRNSNovation of Insurance Liabilities
7th Sep 20187:00 amRNSCorporate Restructuring for Program Business
6th Sep 20187:00 amRNSNotice of Results
4th Sep 20187:00 amRNSR&Q provides $146m legacy reinsurance for USA RRG
4th Sep 20187:00 amRNSIncrease in Borrowing Powers
16th Aug 20187:00 amRNSEuropean program underwriting partnerships
31st Jul 20187:00 amRNSProgram underwriting partnership
11th Jun 20182:24 pmRNSResult of AGM
11th Jun 20187:00 amRNSR&Q complete two transactions
17th May 20187:00 amRNSNotice of AGM and Proposed Return of Capital
1st May 20187:00 amRNSAllotment of Shares
30th Apr 20187:00 amRNSFull year results
25th Apr 20188:00 amRNSAccredited announces underwriting partnership
11th Apr 20188:00 amRNSAccredited begins new program partnership
10th Apr 20188:00 amRNSAM Best affirms Accredited's A- rating
19th Mar 20189:00 amRNSNotice of Results
13th Mar 20187:00 amRNSR&Q completes assignment of liabilities
12th Mar 20187:00 amRNSR&Q completes novation
9th Mar 20189:45 amRNSAdverse Development Cover
19th Feb 201812:45 pmRNSPDMR Share Dealing
19th Feb 20187:00 amRNSCompletion of RITC
5th Feb 20187:00 amRNSAM Best Rating Announcement
24th Jan 20187:00 amRNSR&Q completes assumption from Risk Retention Group
15th Jan 20187:00 amRNSDisposal
9th Jan 20187:00 amRNSAppointment of Executive Director
8th Jan 20187:00 amRNSSenior Management Changes
2nd Jan 20187:14 amRNSAcquisition of Constantia Insurance Company
20th Dec 20172:00 pmRNSReinsurance to Close of Syndicate 3334
11th Dec 20177:00 amRNSUnderwriting Agreement
1st Dec 20177:01 amRNSAccredited Agreement
1st Dec 20177:00 amRNSCompletion of sale of R&Q Managing Agency Limited
2nd Nov 20177:48 amRNSNotification of Major Holdings
1st Nov 20177:00 amRNSAccredited Agreement
31st Oct 20171:34 pmRNSNotification of major interest in shares
31st Oct 201711:16 amRNSNotification of major interest in shares
30th Oct 20172:35 pmRNSResult of General Meeting and Open Offer
30th Oct 20177:10 amRNSAccredited Agreement
30th Oct 20177:00 amRNSAgreement with ProSight Specialty Insurance
6th Oct 20171:18 pmRNSPosting of Circular
5th Oct 20179:11 amRNSPlacing and Open Offer
29th Sep 20173:21 pmRNSResult of General Meeting
21st Sep 20177:00 amRNSR&Q completes assignment of deductible liabilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.